Conundrum of Clinical QTc Monitoring

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 2022 Aug 26

PMID 36018490

Authors

Marek Malik

Affiliations

Soon will be listed here.

Citing Articles

Synchronous recording of magnetocardiographic and electrocardiographic signals.

Pczalski K, Sobiech J, Buchner T, Kornack T, Foley E, Janczak D Sci Rep. 2024; 14(1):4098.

PMID: 38374368 PMC: 11341780. DOI: 10.1038/s41598-024-54126-5.

The QT Interval in Former Very Preterm Infants in Adolescence and Young Adulthood is Not Different from Term-Born Controls.

Vanthienen J, Petrov M, Luu T, Cloutier A, Raaijmakers A, Staessen J Drug Saf. 2023; 46(9):897-904.

PMID: 37505401 PMC: 10442256. DOI: 10.1007/s40264-023-01335-y.

References

Fenichel R, Malik M, Antzelevitch C, Sanguinetti M, Roden D, Priori S . Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol. 2004; 15(4):475-95. PMC: 1544371. DOI: 10.1046/j.1540-8167.2004.03534.x. View

Drew B, Ackerman M, Funk M, Gibler W, Kligfield P, Menon V . Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010; 121(8):1047-60. PMC: 3056123. DOI: 10.1161/CIRCULATIONAHA.109.192704. View

Schwartz P, Woosley R . Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. J Am Coll Cardiol. 2016; 67(13):1639-1650. DOI: 10.1016/j.jacc.2015.12.063. View

Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V . Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2016; 39(1):16-25. DOI: 10.1007/s11096-016-0414-2. View

Tisdale J, Jaynes H, Kingery J, Mourad N, Trujillo T, Overholser B . Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013; 6(4):479-87. PMC: 3788679. DOI: 10.1161/CIRCOUTCOMES.113.000152. View

Vandael E, Vandenberk B, Vandenberghe J, van den Bosch B, Willems R, Foulon V . A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model. Br J Clin Pharmacol. 2018; 84(12):2824-2835. PMC: 6255989. DOI: 10.1111/bcp.13740. View

Warnier M, Rutten F, Souverein P, de Boer A, Hoes A, De Bruin M . Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiol Drug Saf. 2015; 24(7):701-8. DOI: 10.1002/pds.3792. View

Sharma S, Bos J, Tarrell R, Simon G, Morlan B, Ackerman M . Providers' Response to Clinical Decision Support for QT Prolonging Drugs. J Med Syst. 2017; 41(10):161. DOI: 10.1007/s10916-017-0803-7. View

Pezo R, Yan A, Earle C, Chan K . Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs. Heart. 2019; 105(21):1649-1655. DOI: 10.1136/heartjnl-2018-314674. View

10.

Trinkley K, Pell J, Martinez D, Maude N, Hale G, Rosenberg M . Assessing Prescriber Behavior with a Clinical Decision Support Tool to Prevent Drug-Induced Long QT Syndrome. Appl Clin Inform. 2021; 12(1):190-197. PMC: 7946597. DOI: 10.1055/s-0041-1724043. View

11.

Good M, Riad F, Good C, Shalaby A . Provider Response to QTc Prolongation on Standard 12-Lead EKG: Do We Notice or Do We Care?. Pacing Clin Electrophysiol. 2016; 39(11):1174-1180. DOI: 10.1111/pace.12951. View

12.

Putnikovic M, Jordan Z, Munn Z, Borg C, Ward M . Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis. Drug Saf. 2022; 45(10):1037-1048. PMC: 9492585. DOI: 10.1007/s40264-022-01215-x. View

13.

Salem M, Reichlin T, Fasel D, Leuppi-Taegtmeyer A . Torsade de pointes and systemic azole antifungal agents: Analysis of global spontaneous safety reports. Glob Cardiol Sci Pract. 2018; 2017(2):11. PMC: 5871400. DOI: 10.21542/gcsp.2017.11. View

14.

Benjamin L, Elshafey S, Kistler E, Oseran A, Rutledge S, Smith I . Recommendations for QTc Monitoring: Rational or Arbitrary?. Prim Care Companion CNS Disord. 2018; 20(5). DOI: 10.4088/PCC.18f02327. View

15.

Facchini M, Sala L, Malfatto G, Bragato R, Redaelli G, Invitti C . Low-K+ dependent QT prolongation and risk for ventricular arrhythmia in anorexia nervosa. Int J Cardiol. 2005; 106(2):170-6. DOI: 10.1016/j.ijcard.2005.01.041. View

16.

Genovesi S, Nava E, Bartolucci C, Severi S, Vincenti A, Contaldo G . Acute effect of a peritoneal dialysis exchange on electrolyte concentration and QT interval in uraemic patients. Clin Exp Nephrol. 2019; 23(11):1315-1322. DOI: 10.1007/s10157-019-01773-y. View

17.

Drew D, Baranchuk A, Hopman W, Brison R . The impact of fever on corrected QT interval. J Electrocardiol. 2017; 50(5):570-575. DOI: 10.1016/j.jelectrocard.2017.04.006. View

18.

Capparelli F, Abello M, Patricio Maskin L, Arista E, Hlavnicka A, Diaz M . QTc prolongation after brain surgery. Neurol Res. 2013; 35(2):159-62. DOI: 10.1179/1743132813Y.0000000169. View

19.

Lee Y, Choi J, Bae E, Park W, Lee H, Oh P . The corrected QT (QTc) prolongation in hyperthyroidism and the association of thyroid hormone with the QTc interval. Korean J Pediatr. 2015; 58(7):263-6. PMC: 4543186. DOI: 10.3345/kjp.2015.58.7.263. View

20.

Kligfield P, Badilini F, Denjoy I, Babaeizadeh S, Clark E, De Bie J . Comparison of automated interval measurements by widely used algorithms in digital electrocardiographs. Am Heart J. 2018; 200:1-10. DOI: 10.1016/j.ahj.2018.02.014. View